In:
ract, Walter de Gruyter GmbH, Vol. 101, No. 10 ( 2013-10), p. 667-673
Abstract:
89 Sr, a pure beta emitter with half life of 50 . 53 d is used as its chloride solution for palliative care of bone metastases. This paper describes the feasibility studies that have been conducted at FBTR, IGCAR for production of this radionuclide using the 89 Y( n, p ) 89 Sr reaction. Yttria pellets were irradiated in a special subassembly at the core centre for a total of 73 d in two steps of 35 d and 38 d with a time gap of 38 d. The irradiated yttria target was dissolved in nitric acid and the bulk Y was separated by solvent extraction using the TBP-HNO 3 complex. The 89Sr fraction was purified using the cation exchange resin DOWEX 50W×8 (100-200 mesh size) from the other radioactive impurities seen. The eluted 89 Sr fraction was assayed using a GM counting system. The 89 Sr activity produced in 1 g of yttria pellet was found to be 19 mCi.
Type of Medium:
Online Resource
ISSN:
2193-3405
,
0033-8230
DOI:
10.1524/ract.2013.2055
Language:
English
Publisher:
Walter de Gruyter GmbH
Publication Date:
2013
detail.hit.zdb_id:
104-1
detail.hit.zdb_id:
2039575-9
Permalink